Alkem Laboratories · NSE: ALKEM · BSE: 539523
Q3 FY19 results · Oct–Dec 2018
Alkem Laboratories reported revenue from operations of ₹1,925.03 crore and net profit of ₹205.45 crore for Q3 FY19 (Oct–Dec 2018), on a consolidated basis.
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,925.03 | — | — | 1,918.92 | +0.3% |
| Other income | 9.35 | — | — | 24.02 | −61.1% |
| Total income | 1,934.38 | — | — | 1,942.94 | −0.4% |
| Profit before tax | 258.06 | — | — | 326.02 | −20.8% |
| Net profit for the period | 205.45 | — | — | 260.42 | −21.1% |
| Attributable to shareholders of the company | 202.53 | — | — | 254.47 | −20.4% |
| EPS, basic (₹) | 16.94 | — | — | 21.28 | −20.4% |
| Net margin (%) | 10.7 | — | 13.6 |
| Item | Q3 FY19 | Q3 FY18 | YoY | Q2 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,536.03 | — | — | 1,440.22 | +6.7% |
| Other income | 5.75 | — | — | 23.43 | −75.5% |
| Total income | 1,541.78 | — | — | 1,463.65 | +5.3% |
| Profit before tax | 286.92 | — | — | 284.77 | +0.8% |
| Net profit for the period | 241.23 | — | — | 238.30 | +1.2% |
| EPS, basic (₹) | 20.18 | — | — | 19.93 | +1.2% |
| Net margin (%) | 15.7 | — | 16.5 |
Consolidated
- Filed with BSE
- 08 Feb 2019, 18:26 IST
- Board meeting
- 08 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Feb 2019, 18:26 IST
- Board meeting
- 08 Feb 2019
- Period
- 01 Oct 2018 to 31 Dec 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE